450 related articles for article (PubMed ID: 30683111)
1. Role of cholesterol and sphingolipids in brain development and neurological diseases.
Hussain G; Wang J; Rasul A; Anwar H; Imran A; Qasim M; Zafar S; Kamran SKS; Razzaq A; Aziz N; Ahmad W; Shabbir A; Iqbal J; Baig SM; Sun T
Lipids Health Dis; 2019 Jan; 18(1):26. PubMed ID: 30683111
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids: membrane microdomains in brain development, function and neurological diseases.
Olsen ASB; Færgeman NJ
Open Biol; 2017 May; 7(5):. PubMed ID: 28566300
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes?
Róg T; Vattulainen I
Chem Phys Lipids; 2014 Dec; 184():82-104. PubMed ID: 25444976
[TBL] [Abstract][Full Text] [Related]
4. Neuronal membrane dynamics as fine regulator of sphingolipid composition.
Aureli M; Samarani M; Loberto N; Chiricozzi E; Mauri L; Grassi S; Schiumarini D; Prinetti A; Sonnino S
Glycoconj J; 2018 Aug; 35(4):397-402. PubMed ID: 30145639
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and myelin.
Snipes GJ; Suter U
Subcell Biochem; 1997; 28():173-204. PubMed ID: 9090295
[No Abstract] [Full Text] [Related]
6. Monogenic neurological disorders of sphingolipid metabolism.
Sabourdy F; Astudillo L; Colacios C; Dubot P; Mrad M; Ségui B; Andrieu-Abadie N; Levade T
Biochim Biophys Acta; 2015 Aug; 1851(8):1040-51. PubMed ID: 25660725
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids.
Gowrishankar S; Cologna SM; Givogri MI; Bongarzone ER
Neurobiol Dis; 2020 Dec; 146():105142. PubMed ID: 33080336
[TBL] [Abstract][Full Text] [Related]
8. Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.
Piccinini M; Scandroglio F; Prioni S; Buccinnà B; Loberto N; Aureli M; Chigorno V; Lupino E; DeMarco G; Lomartire A; Rinaudo MT; Sonnino S; Prinetti A
Mol Neurobiol; 2010 Jun; 41(2-3):314-40. PubMed ID: 20127207
[TBL] [Abstract][Full Text] [Related]
9. Maternal dietary restriction causes myelin and lipid deficits in the brain of offspring.
Yeh YY
J Neurosci Res; 1988 Mar; 19(3):357-63. PubMed ID: 3379650
[TBL] [Abstract][Full Text] [Related]
10. Roles of sphingolipids in Drosophila development and disease.
Kraut R
J Neurochem; 2011 Mar; 116(5):764-78. PubMed ID: 21214556
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?
Narayan S; Thomas EA
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1797-810. PubMed ID: 21196265
[TBL] [Abstract][Full Text] [Related]
12. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).
Rawat SS; Viard M; Gallo SA; Rein A; Blumenthal R; Puri A
Mol Membr Biol; 2003; 20(3):243-54. PubMed ID: 12893532
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol and lipid rafts in the biological membranes. Role in the release, reception and ion channel functions].
Petrov AM; Zefirov AL
Usp Fiziol Nauk; 2013; 44(1):17-38. PubMed ID: 23662472
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Lipid Rafts (Detergent-Resistant Microdomains) and Comparison to Extracellular Vesicles (Exosomes).
Dawson G
Methods Mol Biol; 2021; 2187():99-112. PubMed ID: 32770503
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction.
Posse de Chaves E; Sipione S
FEBS Lett; 2010 May; 584(9):1748-59. PubMed ID: 20006608
[TBL] [Abstract][Full Text] [Related]
16. The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders.
Giussani P; Prinetti A; Tringali C
J Neurochem; 2021 Feb; 156(4):403-414. PubMed ID: 33448358
[TBL] [Abstract][Full Text] [Related]
17. Brain lipids.
Ramsey RB; Nicholas HJ
Adv Lipid Res; 1972; 10():143-232. PubMed ID: 4565341
[No Abstract] [Full Text] [Related]
18. Sphingolipids in lipid microdomains and obesity.
Mitsutake S; Igarashi Y
Vitam Horm; 2013; 91():271-84. PubMed ID: 23374721
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.
Codini M; Garcia-Gil M; Albi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450869
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol and myelin biogenesis.
Saher G; Simons M
Subcell Biochem; 2010; 51():489-508. PubMed ID: 20213556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
